Failure to Maintain: Missed Care and Hospital-Acquired Pneumonia STTI INDIANAPOLIS, OCTOBER 2017 DIAN BAKER, PHD, RN PROFESSOR, SCHOOL OF NURSING DIBAKER@CSUS.EDU CALIFORNIA STATE UNIVERSITY, SACRAMENTO 1
1. Our journey with NV-HAP, patient safety, and cost impact 2. Review of current literature and our findings from HCUP and the Medicaid databases 3. NV-HAP can be prevented through therapeutic nursing care interventions Next steps for a Call to Action
The story of May and how we began this journey HAPPI = Hospital-acquired pneumonia prevention initiative May is a 57 year old grandmother who develops non-ventilator hospital acquired pneumonia (NV-HAP) Why does this keep happening? Emma Winn Healthy Elderly http://www.fhms.surrey.ac.uk/nutritionandbone/swiss.html 3
Incidence of NV-HAP: Three hospital systems study (2012 used 2010 data) similar results from Kaiser and the VA Sutter Medical Center: 2010 24,482 patients; 94,247 patient days 1.25/1000 pt days & 0.49/100 pts 115 cases NV-HAP Total estimated annual impact: $4.6 million (#cases at extra cost - $40,000/case) 23 deaths 1035 days Quinn, B., Baker, D., et. al. (2014). Basic nursing care to prevent nonventilator hospital-acquired pneumonia. Journal of Nursing Scholarship. 4
We knew VAP was a problem, but what about NV-HAP? Is it a problem too? How much non-ventilator pneumonia was occurring in the hospital? Why was no one talking about it? Was it happening in other hospitals? Can it be prevented? If so, how? 5
Current Literature: NV-HAP is a National Problem Study Incidence/ Cases Mortality +LOS Cost Davis, J. & Finley E. (2012) HCUP National database (AHRQ) (to be published) 5,600 /3 yrs 18.9% Not queried $28,000 2/100 pts 14.5% 4 days $36,400 Magill et al. Point Prevalence Study CDC (2014) PNA 21.8 % of all HAIs > 60% for NV-HAP $40,000 Micek, Chew, Hamptom & Kollef (2016) 174 cases NV-HAP Matched controls equally sick 15.5%vs. 1.6% 8.4 more likely to die 15.9 days vs. 4.4 See et al. (2016) Retrospective review 8 hospitals in PA 2011-2012 VAP excluded 30% of 838 cases reviewed by CDC epidemiologists 30.9% Davis & Finely (2012). Penn Pt Safety Authority, 9(3). Giuliano, et al. (2016) AORN Poster 2016 Magill, et.al. (2014) NEJM. 370(13), p 1198-1208 Micek, et. al. (2016). CHEST, 150(5), 1008-1014. See, et. al. (2016). ICHE, 37, 818-824 doi:10.1017/ice.2016.74 6
7 2014 Data from 21 U.S. hospitals 1300 NV-HAP Cases National HAPPI-2 incidence study 16% mortality 60% occurred on Med/Surg units 27% acquired in ICU/ 19% transferred to ICU 46% of NV-HAP patients spent time in the ICU 33% transferred to ICU died ONLY 60% admitted from home were discharged back to home 19% readmitted within 30 days Cases from these 21 hospitals = $52.5 million in extra costs from a preventable harm ($40,000 additional costs/ case) HAPPI in review, do not distribute
Literature: Pneumonia and Sepsis 50% of sepsis cases are caused by pneumonia (Finfer, 2013) Mayr, et. al. (2014) Epidemiology of severe sepsis, Virulence, 5(1): 4-11 Finfer et. al. (2013) Severe sepsis and septic shock, NEJM, 369:840-51 8
What are you working on right now? Relative Harm: Most common HAIs Type % Prevalence % Mortality Cost CAUTI 13% 1.5% $1,108 CLABSI 5-10% 12% $33,618 SSI >10% 3% $19,305 HAP 22% 19% $40,000 9
Centers for Disease Control and Prevention Included for the first time in its top TEN public health concerns: Healthcare-associated infections #1 Hospital-acquired infection pneumonia * >60% of HAP are from NV-HAP CDC (2015) Prevention Status Report 10
How can non-ventilator hospitalacquired pneumonia be prevented? P11
Most Pneumonia Starts in the Mouth Microbiome of Oral Cavity 200 billion oral microbes 700-1000 species Disruption of Microbiome Risk with hospitalization Changes in saliva ph and production o 48 hours for HAP pathogens in mouth o PLUS MICROASPIRATIONS oif aspirated =100,000,000 bacteria/ml saliva into lungs http://helios.bto.ed.ac.uk/bto/microbes/biofilm.htm / Loesche, W. 2012/ Sacnnapieco et al. 1992).Crit CareMed, 20:740-745 12
This attachment structure requires mechanical removal with a good toothbrush Dental Plaque Biofilms By Jill S. Nield-Gehrig, RDH, MA http://www.2ndchance.inf o/bones-nield- Gehrig2003.pdf 13
Identify the most modifiable risk factors and develop prevention programs to address them. (CDC, 2003) Germs Reduce harmful pathogens with: Comprehensive oral care * applies to all patients/ most modifiable Aspiration Reduce aspiration with: Swallow evals HOB elevated Tube Care Host Increase host resistance with: Early mobility Keep patients warm during surgery Pulmonary toilet Limit use of acid suppressive meds Prevent HAP Quinn & Baker. (2014). J Nsg Scholarship, 46(1), 11-19. 14
Missed care associated with the development of pneumonia* Missed Achieved ELEVATED HOB 34% 66% MOBILITY 59% 41% ORAL CARE 73% 27% IS/C&DB 84% 16% Coker et al. (2016). Obs oral hygiene provided by nurses elder adults. Geriatric Nsg, dx.doi.org/10.106/j.gerinurse.2016) *Kalisch, B. (2013). Am J Med Qual. Missed nursing care leads to poor pt outcomes. *Data from Sutter HAPPI 1 study 15
A Pneumonia Prevention Story
Use Use a scientific implementation and change model - IHI QI process and Influencer Model TM Vital Signs) How We Addressed NV- HAP & Post- Op Pneumonia at our facility Measure Gap Analysis & Gather a Team Measure baseline NV-HAP/ Process rates oral care Control chart and OR/RR and CI chart GAP analysis and Gather an interdisciplinary team Include patients and families Select Select Interventions based on Gap Analysis findings & best available evidence-based practices
1 2 3 4 Focus on one intervention at a time, beginning with the most modifiable risk factors ORAL CARE & Peri-Op oral care Add new tube care protocols Added monitoring of Stress Ulcer Prophylaxis Monitor process and outcome measures; C-chart and calculate return on investment (ROI) Engage leadership Provide frequent feedback to staff, patients, and leadership Celebrate and share your successes Monitor process measurements & engagement Process for Change
NV-HAP 70% from baseline Number of non-ventilator HAP cases 20 18 16 14 12 10 8 6 4 2 0 Control chart for non-ventilator HAP January 2010 to December 2014 Baseline Oral care for all adult pts Documentation Mandatory Education for Nurse Assistants NGT standards revised Pharmacy starts SUP protocol Started oral care prior to surgery JAN 2010 FEB 2010 MAR 2010 APR 2010 MAY 2010 JUN 2010 JUL 2010 AUG 2010 SEP 2010 OCT 2010 NOV 2010 DEC 2010 MAY 2012 JUN 2012 JUL 2012 AUG 2012 SEP 2012 OCT 2012 NOV 2012 DEC 2012 JAN 2013 FEB 2013 MAR 2013 APR 2013 MAY 2013 JUN 2013 JUL 2013 AUG 2013 SEP 2013 OCT 2013 NOV 2013 DEC 2013 JAN 2014 FEB 2014 MAR 2014 APR 2014 MAY 2014 JUL 2014 AUG 2014 SEP 2014 OCT 2014 NOV 2014 DEC 2014 UCL Mean LCL 19
20 Post operative NV-HAP (all adult inpatient surgery) Incidence 6 months pre oral care vs. 6 months after 12 10 8 6 Post Op NV-HAP 4 2 0 Mar- July 14 Aug14-Jan 15
Return on investment: What does pneumonia prevention mean? Between May 2012 and December 2014 we avoided 164 cases of NV-HAP 31 lives saved $5.9 million not spent 656-1476 hospital days avoided Cost analysis: Project HCCaU. National Inpatient Sample 2017 [Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp#purchase accessed April 2017.
Based on numbers from the CDC and NVHAP incidence studies, we estimate that reducing NVHAP by even 50% in the U.S. will save 53,000 lives, 170,000 patient days, and $3.4B annually (based on HCUP total charges) (Commitment statement, WPSF Summit 2016) JOIN US: Email dibaker@csus.edu
National Impact Policy California Healthcare Quality Institute American Dental Association World Patient Safety Foundation American Hospital Association The Joint Commission Centers for Disease Control and Prevention
HAP #1 hospitalacquired infection, costing patient lives and dollars (NV-HAP 60%) Nursing Interventions- HAP can be prevented and harm to patients reduced Monitoring for NV-HAP and prevention programs must rise to the same level of attention as other hospitalacquired infections 24
One must always be aware, to notice, even though the cost of noticing is to become responsible. Thylias Moss dibaker@csus.edu